SIC
GOSS icon

SJS Investment Consulting’s Gossamer Bio GOSS Stock Holding History

SJS Investment Consulting’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137 Buy
830
+125
+18% +$35 ﹤0.01% 2545
2026
Q1 		$232 Buy
705
+646
+1,095% +$1.01K ﹤0.01% 1951
2025
Q4 		$183 Buy
+59
New +$168 ﹤0.01% 1833

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

SJS Investment Consulting's GOSS Position: Q2 2026 in Review

SJS Investment Consulting increased its Gossamer Bio (GOSS) stake by 18% in Q2 2026, buying an estimated $35 and bringing the position to 830 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

SJS Investment Consulting first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $232 in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • SJS Investment Consulting held 830 shares of Gossamer Bio worth $137 as of Q2 2026.
  • SJS Investment Consulting bought 125 Gossamer Bio shares in Q2 2026, an estimated $35.
  • Gossamer Bio made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2545 holding.
  • SJS Investment Consulting first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • SJS Investment Consulting's Gossamer Bio position peaked at $232 in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.